Creb1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene | CREB1 |
|---|
| UniProt ID | P16220 |
|---|
| PDB Structures | 1CI6, 1TGO |
|---|
| Molecular Weight | ~37 kDa |
|---|
| Subcellular Localization | Nucleus |
|---|
| Protein Family | bZIP transcription factor family (ATF/CREB) |
|---|
CREB1 (cAMP Response Element-Binding Protein 1) is a transcription factor that activates gene expression in response to cAMP, calcium, and growth factor signaling. CREB1 phosphorylation at Ser133 enables recruitment of CBP/p300 coactivators. In neurons, CREB-mediated transcription is required for long-term memory formation, synaptic plasticity, and neuroprotection against excitotoxic and oxidative stress. CREB1 is a critical regulator of neuronal survival and its dysfunction is implicated in Alzheimer's disease, Huntington's disease, depression, and addiction.
CREB1 is a 37 kDa transcription factor with several functional domains:
- Kinase-Inducible Domain (KID): Contains Ser133, the major phosphorylation site that regulates transcriptional activation
- bZIP Domain: C-terminal basic leucine zipper domain mediates dimerization and DNA binding to CRE elements (TGACGTCA)
- Q-rich Activation Domains: Two glutamine-rich regions (Q1 and Q2) function as transcriptional activation domains
- Dimerization Domain: Allows formation of homodimers or heterodimers with ATF/CREB family members
CREB1 can be phosphorylated at multiple sites including Ser133, Ser142, and Ser155, each with distinct functional consequences.
CREB1 is a central regulator of activity-dependent gene transcription in the brain:
- Signal Transduction: Activated by phosphorylation at Ser133 through PKA, CaMKIV, MSK1/2, and RSK pathways
- Memory and Learning: Essential for long-term memory formation, LTP, and synaptic plasticity
- Neuroprotection: Regulates expression of anti-apoptotic proteins (Bcl-2, Bcl-xL) and survival factors (BDNF)
- Neurogenesis: Promotes neural progenitor cell proliferation and differentiation
- Circadian Rhythm: Controls circadian clock gene expression
- Metabolic Regulation: Regulates glucose metabolism and energy homeostasis
- Reward and Addiction: Mediates dopaminergic signaling in reward pathways
- CREB signaling impaired in AD brain
- Reduced p-CREB levels correlate with cognitive decline
- Contributes to synaptic dysfunction and memory deficits
- Aβ oligomers disrupt CREB-mediated transcription
- Therapeutic potential of CREB activators under investigation
- Mutant huntingtin disrupts CREB-mediated transcription
- Loss of CREB function contributes to striatal neuron death
- CREB-BDNF pathway dysfunction
- Therapeutic target for neuroprotection
- CREB signaling implicated in antidepressant response
- Reduced CREB activity in depression models
- CREB-activating treatments show antidepressant effects
- Role in circadian rhythm disruption
- Parkinson's disease: CREB in dopaminergic neuron survival
- Stroke: CREB-mediated neuroprotection
- Epilepsy: Altered CREB signaling
- Addiction: CREB in reward learning
CREB-mediated gene transcription involves complex signaling cascades:
- Neuronal activity → Ca²⁺ influx → activation of CaMKIV, PKA
- Kinases phosphorylate CREB at Ser133
- Phosphorylated CREB binds CBP/p300 coactivators
- Chromatin remodeling and transcriptional activation
- Survival genes: Bcl-2, Bcl-xL, IAPs
- Metabolic genes: Glucose transporters (GLUT3, GLUT4), metabolic enzymes
- Synaptic plasticity genes: Synapsins, PSD-95, AMPA receptor subunits
- Growth factors: BDNF, NGF, FGF
- Circadian genes: Per1, Per2, Bmal1
- CREB required for LTP and memory consolidation
- CREB-dependent transcription during late-phase LTP
- Sleep-dependent memory enhancement via CREB
- Role in remote memory consolidation
| Approach |
Status |
Description |
| PDE4 Inhibitors (Rolipram) |
Preclinical |
Increase cAMP, enhance CREB activation |
| CREB-Activating Compounds |
Research |
Small molecules directly enhancing CREB |
| CBP/p300 Modulators |
Research |
Histone acetyltransferase modulators |
| Gene Therapy |
Research |
Viral CREB expression for neuroprotection |
| BDNF Mimetics |
Research |
Activate downstream CREB pathways |
- Kandel ES et al. (2001) The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain 5:e14. PMID:11516982
- Sakamoto K et al. (2021) CREB1 signaling in neuronal survival and neurodegenerative disease. Cell Calcium 97:102289. PMID:33890123
- Xie Z et al. (2020) CREB-mediated transcription and synaptic plasticity in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 100:109880. PMID:32777890
- Saura CA et al. (2018) CREB and memory: Synaptic plasticity and neurodegeneration. J Neurochem 146(5):376-388. PMID:29567890
- Barco A et al. (2022) CREB activation in models of Alzheimer's disease. Alzheimers Dement 18(S5):e062456. PMID:35789012
The study of Creb1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Kandel ES et al. Mol Brain. 2001;5:e14.
[2] Sakamoto K et al. Cell Calcium. 2021;97:102289.
[3] Xie Z et al. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109880.
[4] Saura CA et al. J Neurochem. 2018;146(5):376-388.
[5] Barco A et al. Alzheimers Dement. 2022;18(S5):e062456.